{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:54:08Z","timestamp":1791518048354,"version":"4.3.4"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>The concept that individuals with the same disease and a similar clinical presentation may have very different outcomes and need very different therapies is not novel. With the development of many innovative tools derived from the omics technologies, transplant medicine is slowly entering the era of precision medicine. Biomarkers are the cornerstone of precision medicine, which aims to integrate biomarkers with traditional clinical information and tailor medical care to achieve the best outcome for an individual patient. Here, we discuss the basic concepts of precision medicine and biomarkers, with a specific focus on progress in renal transplantation. We delineate the different types of biomarkers and provide a general assessment of the current applications and shortcomings of previously proposed biomarkers. We also outline the potential of precision medicine in transplantation. Moving toward precision medicine in the field of transplantation will require transplant physicians to embrace the increased complexity and expanded decision algorithms and therapeutic options that are associated with improved disease nosology.<\/jats:p>","DOI":"10.1681\/asn.2017010004","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T21:10:32Z","timestamp":1507583432000},"page":"24-34","source":"Crossref","is-referenced-by-count":110,"title":["Precision Transplant Medicine: Biomarkers to the Rescue"],"prefix":"10.1681","volume":"29","author":[{"given":"Maarten","family":"Naesens","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Laboratory of Nephrology, Katholieke Universiteit Leuven, University of Leuven, Leuven, Belgium;"},{"name":"Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"Anglicheau","sequence":"additional","affiliation":[{"name":"Necker-Enfants Malades Institute, French National Institutes of Health and Medical Research U1151, Paris, France;"},{"name":"Paris Descartes, Sorbonne Paris Cit\u00e9 University, Paris, France;"},{"name":"R\u00e9seau Th\u00e9matique de Recherche et de Soins Centaure, Paris, France;"},{"name":"Labex Transplantex, Paris, France; and"},{"name":"Department of Nephrology and Kidney Transplantation, Necker Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,10,9]]},"reference":[{"key":"B1-20230819","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival.","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"B2-20230819","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.2015010062","article-title":"Proteinuria as a noninvasive marker for renal allograft histology and failure: An Observational Cohort study.","volume":"27","author":"Naesens","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B3-20230819","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1046\/j.1600-6135.2003.00275.x","article-title":"Poor predictive value of serum creatinine for renal allograft loss.","volume":"3","author":"Kaplan","year":"2003","journal-title":"Am J Transplant"},{"key":"B4-20230819","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B5-20230819","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrneph.2013.281","article-title":"Biomarkers for kidney transplant rejection.","volume":"10","author":"Lo","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B6-20230819","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.trre.2014.03.003","article-title":"MicroRNAs as biomarkers of graft outcome.","volume":"28","author":"Amrouche","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"B7-20230819","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nrneph.2010.113","article-title":"Molecular diagnostics in transplantation.","volume":"6","author":"Naesens","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"B8-20230819","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/ajt.14082","article-title":"Urinary microRNA as biomarker in renal transplantation.","volume":"17","author":"van de Vrie","year":"2017","journal-title":"Am J Transplant"},{"key":"B9-20230819","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e318218e978","article-title":"Peripheral blood sampling for the detection of allograft rejection: Biomarker identification and validation.","volume":"92","author":"Heidt","year":"2011","journal-title":"Transplantation"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MOT.0000000000000208","article-title":"Urinary biomarkers of renal transplant outcome.","volume":"20","author":"Ho","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1097\/TP.0000000000001321","article-title":"Establishing biomarkers in transplant medicine: A critical review of current approaches.","volume":"100","author":"Anglicheau","year":"2016","journal-title":"Transplantation"},{"key":"B12-20230819","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/tri.12205","article-title":"Pretransplant identification of acute rejection risk following kidney transplantation.","volume":"27","author":"Lebranchu","year":"2014","journal-title":"Transpl Int"},{"key":"B13-20230819","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.trim.2015.09.006","article-title":"EpViX: A cloud-based tool for epitope reactivity analysis and epitope virtual crossmatching to identify low immunologic risk donors for sensitized recipients.","volume":"33","author":"Anuncia\u00e7\u00e3o","year":"2015","journal-title":"Transpl Immunol"},{"key":"B14-20230819","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.humimm.2016.10.008","article-title":"Should epitope-based HLA compatibility be used in the kidney allocation system?","volume":"78","author":"Duquesnoy","year":"2017","journal-title":"Hum Immunol"},{"key":"B15-20230819","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/01.TP.0000120385.03278.28","article-title":"The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens.","volume":"77","author":"Dankers","year":"2004","journal-title":"Transplantation"},{"key":"B16-20230819","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/ajt.13707","article-title":"Alloantibody responses after renal transplant failure can be better predicted by donor-recipient HLA amino acid sequence and physicochemical disparities than conventional HLA matching.","volume":"16","author":"Kosmoliaptsis","year":"2016","journal-title":"Am J Transplant"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ajt.12968","article-title":"HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: A nested case-control study.","volume":"15","author":"Sapir-Pichhadze","year":"2015","journal-title":"Am J Transplant"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/TP.0000000000001284","article-title":"Strategic use of epitope matching to improve outcomes.","volume":"100","author":"Wiebe","year":"2016","journal-title":"Transplantation"},{"key":"B19-20230819","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"key":"B20-20230819","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trre.2013.07.003","article-title":"Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation.","volume":"27","author":"Zuber","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"B21-20230819","doi-asserted-by":"crossref","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Transl Med"},{"key":"B22-20230819","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.trre.2013.07.004","article-title":"Recurrence of glomerulonephritis after renal transplantation.","volume":"27","author":"Sprangers","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"B23-20230819","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1172\/JCI85265","article-title":"Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.","volume":"126","author":"Tomas","year":"2016","journal-title":"J Clin Invest"},{"key":"B24-20230819","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/ajt.13042","article-title":"Advances in the understanding of complement mediated glomerular disease: Implications for recurrence in the transplant setting.","volume":"15","author":"Barbour","year":"2015","journal-title":"Am J Transplant"},{"key":"B25-20230819","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2014.217","article-title":"Histopathology of MPGN and C3 glomerulopathies.","volume":"11","author":"Cook","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B26-20230819","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(16)00272-5","article-title":"Primary glomerulonephritides.","volume":"387","author":"Floege","year":"2016","journal-title":"Lancet"},{"key":"B27-20230819","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/TP.0000000000001093","article-title":"Recurrent IgA nephropathy after kidney transplantation.","volume":"100","author":"Wyld","year":"2016","journal-title":"Transplantation"},{"key":"B28-20230819","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneph.2010.141","article-title":"Management of cytomegalovirus infection in solid organ transplantation.","volume":"6","author":"Kotton","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"B29-20230819","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrneph.2012.64","article-title":"Management of polyomavirus-associated nephropathy in renal transplant recipients.","volume":"8","author":"Kuypers","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B30-20230819","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1111\/ajt.13891","article-title":"Urinary mRNA for the diagnosis of renal allograft rejection: The issue of normalization.","volume":"16","author":"Galichon","year":"2016","journal-title":"Am J Transplant"},{"key":"B31-20230819","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1215555","article-title":"Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.","volume":"369","author":"Suthanthiran","year":"2013","journal-title":"N Engl J Med"},{"key":"B32-20230819","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/ajt.12671","article-title":"Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling.","volume":"14","author":"Kurian","year":"2014","journal-title":"Am J Transplant"},{"key":"B33-20230819","doi-asserted-by":"crossref","first-page":"e1001759","DOI":"10.1371\/journal.pmed.1001759","article-title":"The kSORT assay to detect renal transplant patients at high risk for acute rejection: Results of the multicenter AART study.","volume":"11","author":"Roedder","year":"2014","journal-title":"PLoS Med"},{"key":"B34-20230819","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"B35-20230819","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 kidney meeting report: Current challenges in rejection classification and prospects for adopting molecular pathology.","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"key":"B36-20230819","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nrneph.2016.85","article-title":"Molecular assessment of disease states in kidney transplant biopsy samples.","volume":"12","author":"Halloran","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B37-20230819","article-title":"Real time central assessment of kidney transplant indication biopsies by microarrays: The INTERCOMEX study [published online ahead of print April 27, 2017].","author":"Halloran","journal-title":"Am J Transplant"},{"key":"B38-20230819","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff \u201909 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups.","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"B39-20230819","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival.","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"B40-20230819","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B41-20230819","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MOT.0000000000000324","article-title":"Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation.","volume":"21","author":"Viglietti","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"B42-20230819","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1172\/JCI41789","article-title":"A molecular classifier for predicting future graft loss in late kidney transplant biopsies.","volume":"120","author":"Einecke","year":"2010","journal-title":"J Clin Invest"},{"key":"B43-20230819","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(16)30826-1","article-title":"Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: A multicentre, prospective study.","volume":"388","author":"O\u2019Connell","year":"2016","journal-title":"Lancet"},{"key":"B44-20230819","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/TP.0000000000001512","article-title":"Foretelling graft outcome by molecular evaluation of renal allograft biopsies: The GoCAR study.","volume":"101","author":"Yazdani","year":"2017","journal-title":"Transplantation"},{"key":"B45-20230819","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1681\/ASN.2013111149","article-title":"Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection.","volume":"25","author":"Loupy","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B46-20230819","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/ajt.12150","article-title":"Molecular diagnosis of antibody-mediated rejection in human kidney transplants.","volume":"13","author":"Sellar\u00e9s","year":"2013","journal-title":"Am J Transplant"},{"key":"B47-20230819","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/sim.5403","article-title":"Biomarkers and surrogate endpoints in clinical trials.","volume":"31","author":"Fleming","year":"2012","journal-title":"Stat Med"},{"key":"B48-20230819","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMc1602859","article-title":"Belatacept and long-term outcomes in kidney transplantation.","volume":"374","author":"Naesens","year":"2016","journal-title":"N Engl J Med"},{"key":"B49-20230819","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation.","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"B50-20230819","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1600-6143.2010.03104.x","article-title":"The elephant in the room: Failings of current clinical endpoints in kidney transplantation.","volume":"10","author":"Schold","year":"2010","journal-title":"Am J Transplant"},{"key":"B51-20230819","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"B52-20230819","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity.","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B53-20230819","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.08570814","article-title":"Immunosuppressive medications.","volume":"11","author":"Wiseman","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B54-20230819","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3182977ab1","article-title":"Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.","volume":"96","author":"Franco Palacios","year":"2013","journal-title":"Transplantation"},{"key":"B55-20230819","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.clinbiochem.2015.08.010","article-title":"Biomarkers to assess donor-reactive T-cell responses in kidney transplant patients.","volume":"49","author":"Crespo","year":"2016","journal-title":"Clin Biochem"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201801000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:29:55Z","timestamp":1786130995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201801000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,9]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2017010004","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,9]]}}}